Evolent Health (EVH) Cost of Revenue (2015 - 2026)

Evolent Health's Cost of Revenue history runs 12 years deep, the most recent figure standing at $412.5 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 8.21% year-over-year to $412.5 million; the TTM figure through Mar 2026 stood at $1.5 billion (down 25.84% YoY), while the FY2025 annual figure was $1.5 billion, down 32.51% from the prior year.
• Cost of Revenue was $412.5 million for Q1 2026 at Evolent Health, up from $371.5 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $570.8 million in Q4 2024 to a low of $219.7 million in Q1 2022.
• Historically, Cost of Revenue has averaged $389.1 million across 5 years, with a median of $379.8 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue surged 82.01% in 2022, then plunged 36.34% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $299.4 million in 2022, then soared by 51.8% to $454.4 million in 2023, then gained by 25.62% to $570.8 million in 2024, then plunged by 34.93% to $371.5 million in 2025, then increased by 11.04% to $412.5 million in 2026.
• The last three Cost of Revenue figures came in at $412.5 million (Q1 2026), $371.5 million (Q4 2025), and $379.8 million (Q3 2025), per Business Quant data.